Dermatologic Manifestations of Tuberous Sclerosis Complex (TSC)

Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics

Volumn , Issue , 2010, Pages 285-309

  Darling, Thomas N ^a   Moss, Joel ^b   Mausner, Mark ^c  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Mausner Plastic Surgery Center   (United States)

Author keywords

Angiofibromas; Hypopigmented macules; Shagreen patch; Skin tumors; Tuberous sclerosis complex; Ungual fibromas

Indexed keywords

EID: 84884525619     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527630073.ch14     Document Type: Chapter

References (73)

1. Hunt, A. (1983) Tuberous sclerosis: a survey of 97 cases. II. Physical findings. Dev. Med. Child Neurol., 25, 350-352.
2. Fitzpatrick, T.B. (1991) History and significance of white macules, earliest visible sign of tuberous sclerosis. Ann. N.Y. Acad. Sci, 615, 26-35.
3. Webb, D.W., Clarke, A., Fryer, A., and Osborne, J.P. (1996) The cutaneous features of tuberoussclerosis: a population study. Br. J. Dermatol, 135, 1-5.
4. Jimbow, K. (1997) Tuberous sclerosis and guttate leukodermas. Semin. Cutan. Med. Surg, 16, 30-35.
5. Jozwiak, S., Schwartz, R.A., Janniger, C.K., Michalowicz, R., and Chmielik, J. (1998) Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int. J. Dermatol, 37, 911-917.
6. Dabora, S.L., Jozwiak, S., Franz, D.N., Roberts, P.S., Nieto, A., Chung, J., Choy, Y.S., Reeve, M.P. et al. (2001) Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet, 68, 64-80.
7. Sogut, A., Ozmen, M., Sencer, S., Caliskan, M., Aydinli, N., Ertugrul, T., and Peksayar, G. (2002) Clinical features of tuberous sclerosis cases. Turk. J. Pediatr, 44, 98-101.
8. Sun, X.F., Yan, C.L., Fang, L., Shen, F.M., and Liao, K.H. (2005) Cutaneous lesions and visceral involvement of tuberous sclerosis. Chin. Med. J. (Engl.), 118, 215-219.
9. Datta, A.N., Hahn, C.D., and Sahin, M. (2008) Clinical presentation and diagnosis of tuberous sclerosis complex in infancy. J. Child Neurol, 23, 268-273.
10. Schwartz, R.A., Fernandez, G., Kotulska, K., and Jozwiak, S. (2007) Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J. Am. Acad. Dermatol, 57, 189-202.
11. Schaffer, J.V. and Bolognia, J.L. (2003) The treatment of hypopigmentation in children. Clin. Dermatol., 21, 296-310.
12. Bolognia, J.L. (1999) Aclinical approach to leukoderma. Int. J. Dermatol, 38, 568-572.
13. Sanchez, N.P., Wick, M.R., and Perry, H.O. (1981) Adenoma sebaceum of Pringle: a clinicopathologic review, with a discussion of related pathologic entities. J. Cutan. Pathol, 8, 395-403.
14. Hall, M.R., Kovach, B.T., and Miller, J.L. (2007) Unilateral facial angiofibromas without other evidence of tuberous sclerosis: case report and review of the literature. Cutis, 80, 284-288.
15. Nickel, W.R. and Reed, W.B. (1962) Tuberous sclerosis. Special reference to the microscopic alterations in the cutaneous hamartomas. Arch. Dermatol, 85, 209-226.
16. Earnest, L., Byrne, P., and Califano, J. (2003) Massive facial angiofibroma in a patient with tuberous sclerosis. Otolaryngol. Head Neck Surg, 128, 151-153.
17. Reed, R.J. and Ackerman, A.B. (1973) Pathology of the adventitial dermis. Anatomic observations and biologic speculations. Hum. Pathol, 4, 207-217.
18. Asgharian, B., Turner, M.L., Gibril, F., Entsuah, L.K., Serrano, J., and Jensen, R.T. (2004) Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1. J. Clin. Endocrinol. Metab, 89, 5328-5336.
19. Darling, T.N., Skarulis, M.C., Steinberg, S.M., Marx, S.J., Spiegel, A.M., and Turner, M. (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch. Dermatol, 133, 853-857.
20. Hoang-Xuan, T. and Steger, J.W. (1999) Adult-onset angiofibroma and multiple endocrine neoplasia type I. J. Am. Acad. Dermatol, 41, 890-892.
21. Sakurai, A., Matsumoto, K., Ikeo, Y., Nishio, S.I., Kakizawa, T., Arakura, F., Ishihara, Y., Saida, T. et al. (2000) Frequency of facial angiofibromas in Japanese patients with multiple endocrine neoplasia type 1. Endocr. J, 47, 569-573.
22. Schaffer, J.V., Gohara, M.A., McNiff, J.M., Aasi, S.Z., and Dvoretzky, I. (2005) Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dube syndrome. J. Am. Acad. Dermatol., 53, S108-S111.
23. Bansal, C., Stewart, D., Li, A., and Cockerell, C.J. (2005) Histologic variants of fibrous papule. J. Cutan. Pathol, 32, 424-428.
24. Lee, D.A., Grossman, M.E., Schneiderman, P., and Celebi, J.T. (2005) Genetics of skin appendage neoplasms and related syndromes. J. Med. Genet, 42, 811-819.
25. Vincent, A., Farley, M., Chan, E., and James, W.D. (2003) Birt-Hogg-Dube syndrome: a review of the literature and the differential diagnosis of firm facial papules. J. Am. Acad. Dermatol, 49, 698-705.
26. Toro, J.R., Glenn, G., Duray, P., Darling, T.,Weirich, G., Zbar, B., Linehan, M., and Turner, M.L. (1999) Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia. Arch. Dermatol, 135, 1195-1202.
27. Fryer, A.E., Osborne, J.P., and Schutt, W. (1987) Forehead plaque: a presenting skin sign in tuberous sclerosis. Arch. Dis. Child, 62, 292-293.
28. Menascu, S. and Donner, E.J. (2008) Linear nevus sebaceous syndrome: case reports and review of the literature. Pediatr. Neurol., 38, 207-210.
29. Kawamura, A., Ochiai, T., Tan-Kinoshita, M., and Suzuki, H. (2005) Buschke-Ollendorff syndrome: three generations in a Japanese family. Pediatr. Dermatol, 22, 133-137.
30. Weintraub, R. and Pinkus, H. (1977) Multiple fibrofolliculomas (Birt-Hogg-Dube) associated with a large connective tissue nevus. J. Cutan. Pathol, 4, 289-299.
31. Requena, L., Gutierrez, J., and Sanchez Yus, E. (1992) Multiple sclerotic fibromas of the skin. A cutaneous marker of Cowden's disease. J. Cutan. Pathol, 19, 346-351.
32. Uitto, J., Santa Cruz, D.J., and Eisen, A.Z. (1980) Connective tissue nevi of the skin. clinical, genetic, and histopathologic classification of hamartomas of the collagen, elastin, and proteoglycan type. J. Am. Acad. Dermatol, 3, 441-461.
33. Kint, A. and Baran, R. (1988) Histopathologic study of Koenen tumors. Are they different from acquired digital fibrokeratoma? J. Am. Acad. Dermatol, 18, 369-372.
34. Carlson, R.M., Lloyd, K.M., and Campbell, T.E. (2007) Acquired periungual fibrokeratoma: a case report. Cutis, 80, 137-140.
35. Dereure, O., Savoy, D., Doz, F., Junien, C., and Guilhou, J.J. (2000) Multiple acral fibromas in a patient with familial retinoblastoma: a cutaneous marker of tumour-suppressor gene germline mutation? Br. J. Dermatol, 143, 856-859.
36. Bardazzi, F., Neri, I., Fanti, P.A., and Patrizi, A. (1996) Pachydermodactyly in two young girls. Pediatr. Dermatol, 13, 288-291.
37. Lo, W.L. and Wong, C.K. (1993) Localized pachydermodactyly in tuberous sclerosis. Clin. Exp. Dermatol., 18, 146-147.
38. Vanderhooft, S.L., Francis, J.S., Pagon, R.A., Smith, L.T., and Sybert, V.P. (1996) Prevalence of hypopigmented macules in a healthy population. J. Pediatr, 129, 355-361.
39. Roach, E.S., Gomez, M.R., and Northrup, H. (1998) Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J. Child Neurol, 13, 624-628.
40. Zeller, J., Friedmann, D., Clerici, T., and Revuz, J. (1995) The significance of a single periungual fibroma: report of seven cases. Arch. Dermatol, 131, 1465-1466.
41. Kojima, T., Nagano, T., and Uchida, M. (1987) Periungual fibroma. J. Hand. Surg. [Am.], 12, 465-470.
42. Darling, T.N. (2006) Hitting the mark in hamartoma syndromes. Adv. Dermatol, 22, 181-200.
43. Benjamin, D.R. (1996) Cellular composition of the angiofibromas in tuberous sclerosis. Pediatr. Pathol. Lab. Med, 16, 893-899.
44. Arbiser, J.L., Brat, D., Hunter, S., D'Armiento, J., Henske, E.P., Arbiser, Z.K., Bai, X., Goldberg, G. et al. (2002) Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. J. Am. Acad. Dermatol, 46, 376-380.
45. Li, S., Takeuchi, F., Wang, J.A., Fan, Q., Komurasaki, T., Billings, E.M., Pacheco-Rodriguez, G., Moss, J. et al. (2008) Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas. Proc. Natl. Acad. Sci. USA, 105, 3539-3544.
46. Fackler, I., DeClue, J.E., Rust, H., Vu, P.A., Kutzner, H., Rutten, A., Kaddu, S., Sander, C.A. et al. (2003) Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas. J. Cutan. Pathol, 30, 174-177.
47. Hofbauer, G.F., Marcollo-Pini, A., Corsenca, A., Kistler, A.D., French, L.E., Wuthrich, R.P., and Serra, A.L. (2008) The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis. Br. J. Dermatol, 159, 473-475.
48. Rauktys, A., Lee, N., Lee, L., and Dabora, S.L. (2008) Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model. BMC Dermatol., 8, 1.
49. Nguyen-Vu, P.A., Fackler, I., Rust, A., DeClue, J.E., Sander, C.A., Volkenandt, M., Flaig, M., Yeung, R.S. et al. (2001) Loss of tuberin, the tuberous-sclerosiscomplex-2 gene product is associated with angiogenesis. J. Cutan. Pathol, 28, 470-475.
50. Li, S., Takeuchi, F., Wang, J.A., Fuller, C., Pacheco-Rodriguez, G., Moss, J., and Darling, T.N. (2005) MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development. J. Exp. Med, 202, 617-624.
51. Uysal, H. and Hemming, F.W. (1999) Changes in the expression and distribution of fibronectin, laminin and tenascin by cultured fibroblasts from skin lesions of patients with tuberous sclerosis. Br. J. Dermatol, 141, 658-666.
52. Uysal, H., Saxton, J., and Hemming, F.W. (1997) Changes in the secretion and glycosylation of fibronectin by human skin fibroblasts associated with tuberous sclerosis. Glycoconj. J, 14, 439-447.
53. Papakonstantinou, E., Dionyssopoulos, A., Pesintzaki, C., Minas, A., and Karakiulakis, G. (2003) Expression of proteoglycans and glycosaminoglycans in angiofibroma and fibrous plaque skin lesions from patients with tuberous sclerosis. Arch. Dermatol. Res, 295, 138-145.
54. Papakonstantinou, E., Dionyssopoulos, A., Aletras, A.J., Pesintzaki, C., Minas, A., and Karakiulakis, G. (2004) Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis. J. Am. Acad. Dermatol, 51, 526-533.
55. Kane, Y. (2004) The "bumps" onmyface. J. Am. Acad. Dermatol., 51, S11-S12.
56. Sweeney, S.M. (2004) Pediatric dermatologic surgery: a surgical approach to the cutaneous features of tuberous sclerosis complex. Adv. Dermatol, 20, 117-135.
57. Capurro, S. and Fiallo, P. (2001) Timed surgery for treatment of angiofibromas in tuberous sclerosis. Dermatol. Surg, 27, 486-488.
58. Menon, P.A. (1982) Dermabrasion for the management of angiofibromas in tuberous sclerosis. J. Dermatol. Surg. Oncol, 8, 984-985.
59. Drake, D.B., Morgan, R.F., and Cooper, P.H. (1992) Shave excision and dermabrasion for facial angiofibroma in tuberous sclerosis. Ann. Plast. Surg, 28, 377-380.
60. Fischer, K., Blain, B., Zhang, F., Richards, L., and Lineaweaver, W.C. (2001) Treatment of facial angiofibromas of tuberous sclerosis by shave excision and dermabrasion in a dark-skinned patient. Ann. Plast. Surg, 46, 332-335.
61. Widgerow, A.D. (1989) Shaving and dermabrasion of the facial lesions in tuberous sclerosis. A case report. S. Afr. Med. J, 76, 169-170.
62. Verheyden, C.N. (1996) Treatment of the facial angiofibromas of tuberous sclerosis. Plast. Reconstr. Surg, 98, 777-783.
63. Arndt, K.A. (1982) Adenoma sebaceum: successful treatment with the argon laser. Plast. Reconstr. Surg, 70, 91-93.
64. Pasyk, K.A. and Argenta, L.C. (1988) Argon laser surgery of skin lesions in tuberous sclerosis. Ann. Plast. Surg, 20, 426-433.
65. Kaufman, A.J., Grekin, R.C., Geisse, J.K., and Frieden, I.J. (1995) Treatment of adenoma sebaceum with the copper vapor laser. J. Am. Acad. Dermatol., 33, 770-774.
66. Cole, R.P., Widdowson, D., and Moore, J.C. (2008) Outcome of erbium:yttrium aluminium garnet laser resurfacing treatments. Lasers Med. Sci, 23, 427-433.
67. Tope, W.D. and Kageyama, N. (2001) "Hot" KTP-laser treatment of facial angiofibromata. Lasers Surg. Med, 29, 78-81.
68. Bellack, G.S. and Shapshay, S.M. (1986) Management of facial angiofibromas in tuberous sclerosis: use of the carbon dioxide laser. Otolaryngol. Head. Neck. Surg, 94, 37-40.
69. Bittencourt, R.C.,Huilgol, S.C., Seed, P.T., Calonje, E.,Markey, A.C., and Barlow, R.J. (2001) Treatment of angiofibromas with a scanning carbon dioxide laser: a clinicopathologic study with long-term follow-up. J. Am. Acad. Dermatol, 45, 731-735.
70. Song, M.G., Park, K.B., and Lee, E.S. (1999) Resurfacing of facial angiofibromas in tuberous sclerosis patients using CO2 laser with flashscanner. Dermatol. Surg, 25, 970-973.
71. Boixeda, P., Sanchez-Miralles, E., Azana, J.M., Arrazola, J.M., Moreno, R., and Ledo, A. (1994) CO2, argon, and pulsed dye laser treatment of angiofibromas. J. Dermatol. Surg. Oncol, 20, 808-812.
72. Papadavid, E., Markey, A., Bellaney, G., and Walker, N.P. (2002) Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis. Br. J. Dermatol, 147, 337-342.
73. Janniger, C.K. and Goldberg, D.J. (1990) Angiofibromas in tuberous sclerosis: comparison of treatment by carbon dioxide and argon laser. J. Dermatol. Surg. Oncol, 16, 317-320.